Suppr超能文献

危重症儿童连续性肾脏替代治疗开始时间、肾损伤和血容量过多的影响。

Impact of Continuous Renal Replacement Therapy Initiation Time, Kidney Injury, and Hypervolemia in Critically Ill Children.

机构信息

Sierra Hadley is an acute care pediatric nurse practitioner in the pediatric intensive care unit at Children's Hospital Los Angeles, California.

Julie Thompson is a consulting associate at the Duke University School of Nursing, Durham, North Carolina.

出版信息

Crit Care Nurse. 2024 Jun 1;44(3):28-35. doi: 10.4037/ccn2024440.

Abstract

BACKGROUND

The mortality rate of pediatric patients who require continuous renal replacement therapy is approximately 42%, and outcomes vary considerably depending on underlying disease, illness severity, and time of dialysis initiation. Delay in the initiation of such therapy may increase mortality risk, prolong intensive care unit stay, and worsen clinical outcomes.

LOCAL PROBLEM

In the pediatric intensive care unit of an urban level I trauma children's hospital, continuous renal replacement therapy initiation times and factors associated with delays in therapy were unknown.

METHODS

This quality improvement process involved a retrospective review of data on patients who received continuous dialysis in the pediatric intensive care unit from January 1, 2017, to December 31, 2021. The objectives were to examine the characteristics of the children requiring continuous renal replacement therapy, therapy initiation times, and factors associated with initiation delays that might affect unit length of stay and mortality.

RESULTS

During the study period, 175 patients received continuous renal replacement therapy, with an average initiation time of 11.9 hours. Statistically significant associations were found between the degree of fluid overload and mortality (P < .001) and between the presence of acute kidney injury and prolonged length of stay (P = .04). No significant association was found between therapy initiation time and unit length of stay or mortality, although the average initiation time of survivors was 5.9 hours shorter than that of nonsurvivors.

CONCLUSION

Future studies are needed to assess real time delays and to evaluate if the implementation of a standardized initiation process decreases initiation time.

摘要

背景

需要持续肾脏替代治疗的儿科患者的死亡率约为 42%,死亡率因基础疾病、疾病严重程度和透析开始时间而异。延迟开始此类治疗可能会增加死亡风险、延长重症监护病房的停留时间并恶化临床结果。

本地问题

在城市一级创伤儿童医院的儿科重症监护病房中,持续肾脏替代治疗的开始时间以及与治疗延迟相关的因素尚不清楚。

方法

本质量改进过程涉及对 2017 年 1 月 1 日至 2021 年 12 月 31 日期间在儿科重症监护病房接受连续透析的患者的数据进行回顾性审查。目的是检查需要持续肾脏替代治疗的儿童的特征、治疗开始时间以及与启动延迟相关的因素,这些因素可能会影响单位停留时间和死亡率。

结果

在研究期间,175 名患者接受了持续肾脏替代治疗,平均开始时间为 11.9 小时。液体超负荷程度与死亡率之间存在统计学显著关联(P <.001),急性肾损伤与延长的住院时间之间存在统计学显著关联(P =.04)。治疗开始时间与单位停留时间或死亡率之间没有显著关联,尽管幸存者的平均开始时间比非幸存者短 5.9 小时。

结论

需要进一步研究以评估实时延迟,并评估是否实施标准化启动流程可以缩短启动时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验